Relationship between anthropometric measures and the risk of incident Metabolic dysfunction-associated steatotic liver disease: a longitudinal study

被引：0
|
作者：
Takahiro Ichikawa [1 ]
Yoshitaka Hashimoto [1 ]
Takuro Okamura [2 ]
Akihiro Obora [1 ]
Takao Kojima [3 ]
Hiroshi Okada [3 ]
Masahide Hamaguchi [1 ]
Michiaki Fukui [1 ]
机构：
[1] Kyoto Prefectural University of Medicine,Department of Endocrinology and Metabolism, Graduate School of Medical Science
[2] Matsushita Memorial Hospital,Department of Diabetes and Endocrinology
[3] Asahi University Hospital,Department of Gastroenterology
来源：
BMC Gastroenterology | / 25卷 / 1期
关键词：
Anthropometric measure; MASLD; Japan; Cohort;
D O I：
10.1186/s12876-025-03780-8
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort study
    Moon, Joon Ho
    Jeong, Seogsong
    Jang, Heejoon
    Koo, Bo Kyung
    Kim, Won
    ECLINICALMEDICINE, 2023, 65
  • [2] Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease
    Lee, Hyeok-Hee
    Lee, Han Ah
    Kim, Eun-Jin
    Kim, Hwi Young
    Kim, Hyeon Chang
    Ahn, Sang Hoon
    Lee, Hokyou
    Kim, Seung Up
    GUT, 2024, 73 (03) : 533 - 540
  • [3] Cardiovascular Risk Reduction in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis
    Bernhard, Johannes
    Galli, Lukas
    Speidl, Walter S.
    Krychtiuk, Konstantin A.
    CURRENT CARDIOLOGY REPORTS, 2025, 27 (01)
  • [4] Metabolic Dysfunction-Associated Steatotic Liver Disease
    Ali, Sajjadh M. J.
    Lai, Michelle
    ANNALS OF INTERNAL MEDICINE, 2025, 178 (01) : ITC1 - ITC17
  • [5] Metabolic dysfunction-associated steatotic liver disease and cancer risk: A cohort study
    Peng, Yu
    Wang, Peng
    Liu, Fubin
    Wang, Xixuan
    Si, Changyu
    Gong, Jianxiao
    Zhou, Huijun
    Gu, Jiale
    Qin, Ailing
    Song, Weijie
    Song, Fangfang
    DIABETES OBESITY & METABOLISM, 2025, 27 (04): : 1940 - 1949
  • [6] Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease with Increased Alcohol Intake Increase the Risk of Developing Hepatocellular Carcinoma and Incident or Decompensated Cirrhosis: A Korean Nationwide Study
    Kim, Gi-Ae
    Jeong, Seogsong
    Jang, Heejoon
    Lee, Dong Hyeon
    Joo, Sae Kyung
    Kim, Won
    LIVER CANCER, 2024, 13 (04) : 426 - 437
  • [7] Metabolic dysfunction-associated steatotic liver disease as a cardiovascular risk factor
    Platek, Anna E.
    Szymanska, Anna
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2023, 9 (03) : 187 - 192
  • [8] Prevalence and Risk Factors of Metabolic Dysfunction-associated Steatotic Liver Disease
    Plaza-Aulestia, Nahia
    Ibarguengoitia-Barrena, Oihane
    Sampedro-Andrada, Blanca
    Juan-Lopez, Cristina San
    Morillo-Montanes, Victoria
    Urionaguena, Irati
    Calvo, Itziar
    Seisdedos, David Montero
    Vega-Alvarez, Lucia
    Llorente, Jose Francisco Garcia
    Revenga, Nuria Vegas
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4669 - 4671
  • [9] Genetic Risk Factors for Metabolic Dysfunction-Associated Steatotic Liver Disease
    Pei, Yiying
    Goh, George Boon-Bee
    GUT AND LIVER, 2025, 19 (01) : 8 - 18
  • [10] GASTROINTESTINAL MALIGNANCY RISK IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
    Nwankwo, Chizoba N.
    Eun, Yong
    Nwankwo, Obinna T.
    Osman, Mohamed K.
    Culpepper-Morgan, Joan A.
    GASTROENTEROLOGY, 2024, 166 (05) : S1474 - S1474
12345